Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R.

BMJ. 2000 May 20;320(7246):1373-8.

PMID:
10818026
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group.

BMJ. 2008 May 24;336(7654):1177-80. doi: 10.1136/bmj.39526.674873.BE. Epub 2008 Apr 17.

PMID:
18420663
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

Clarke PM, Gray AM, Briggs A, Stevens RJ, Matthews DR, Holman RR; UKPDS 72 United Kingdom Prospective Diabetes Study.

Diabetologia. 2005 May;48(5):868-77. Epub 2005 Apr 15.

PMID:
15834550
[PubMed - indexed for MEDLINE]
5.

Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.

Tunis SL.

Appl Health Econ Health Policy. 2011 Nov 1;9(6):351-65. doi: 10.2165/11594270-000000000-00000.

PMID:
21892840
[PubMed - indexed for MEDLINE]
6.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
7.
8.

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

CDC Diabetes Cost-effectiveness Group.

JAMA. 2002 May 15;287(19):2542-51.

PMID:
12020335
[PubMed - indexed for MEDLINE]
9.
10.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

[No authors listed]

Lancet. 1998 Sep 12;352(9131):854-65. Erratum in: Lancet 1998 Nov 7;352(9139):1558.

PMID:
9742977
[PubMed - indexed for MEDLINE]
11.

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

Gray A, Clarke P, Farmer A, Holman R; United Kingdom Prospective Diabetes Study (UKPDS) Group.

BMJ. 2002 Oct 19;325(7369):860.

PMID:
12386035
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

Wake N, Hisashige A, Katayama T, Kishikawa H, Ohkubo Y, Sakai M, Araki E, Shichiri M.

Diabetes Res Clin Pract. 2000 Jun;48(3):201-10.

PMID:
10802159
[PubMed - indexed for MEDLINE]
13.

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.

PMID:
19254484
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin.

Cameron C, Coyle D, Ur E, Klarenbach S.

CMAJ. 2010 Jan 12;182(1):28-34. doi: 10.1503/cmaj.090765. Epub 2009 Dec 21.

PMID:
20026626
[PubMed - indexed for MEDLINE]
Free PMC Article
15.
16.

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3. Review.

PMID:
22258959
[PubMed - indexed for MEDLINE]
17.

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes.

Palmer AJ, Dinneen S, Gavin JR 3rd, Gray A, Herman WH, Karter AJ.

Curr Med Res Opin. 2006 May;22(5):861-72.

PMID:
16709308
[PubMed - indexed for MEDLINE]
18.

Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China.

Xie X, Vondeling H.

Value Health. 2008 Mar;11 Suppl 1:S23-32. doi: 10.1111/j.1524-4733.2008.00363.x.

PMID:
18387063
[PubMed - indexed for MEDLINE]
19.

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.

PMID:
16707070
[PubMed - indexed for MEDLINE]
Free Article
20.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk